Frontiers in Cardiovascular Medicine (Feb 2024)

Complexity of coronary artery disease and the release of cardiac biomarkers after CABG

  • Leo Pölzl,
  • Ronja Lohmann,
  • Philipp Sterzinger,
  • Felix Nägele,
  • Jakob Hirsch,
  • Michael Graber,
  • Clemens Engler,
  • Jonas Eder,
  • Hannes Abfalterer,
  • Hanno Ulmer,
  • Andrea Griesmacher,
  • Michael Grimm,
  • Nikolaos Bonaros,
  • Elfriede Ruttmann-Ulmer,
  • Johannes Holfeld,
  • Can Gollmann-Tepeköylü

DOI
https://doi.org/10.3389/fcvm.2024.1345439
Journal volume & issue
Vol. 11

Abstract

Read online

ObjectiveIn patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release. Therefore, this study investigated the correlation between the complexity of CAD, reflected by the SYNTAX Score, and the release of cardiac biomarkers after CABG.MethodsIn a consecutive series of 919 patients undergoing isolated CABG SYNTAX scores I and II were calculated to assess the complexity of CAD. Levels of high sensitivity cardiac troponin T (hs-cTnT) and creatine kinase-myocardial band (CK-MB) were routinely measured once before and serially after surgery. Patients were divided into tertiles according to their SYNTAX Scores I and II. Spearman correlations and regression models were performed to measure the degree of association between the release of hs-cTnT and CK-MB and the SYNTAX Scores.ResultsPatients with a higher SYNTAX Score I had more comorbidities reflected in a higher EuroSCORE II. Preoperatively, higher levels of cardiac biomarkers were found in patients with higher SYNTAX Score II. No correlation was observed between hs-cTnT, CK-MB and SYNTAX Score I or II. Regression models did not show any association between cardiac biomarkers and the complexity of CAD.ConclusionThe complexity of CAD is not associated with the release of cardiac biomarkers after CABG. Factors influencing postoperative biomarker release need to be elucidated in future trials to include postoperative biomarker release into risk stratification models predicting outcome after cardiac surgery.

Keywords